Northwestern University IRB: STU00202090
Principal Investigators: Katherine L. Wisner, MD MS (Department of Psychiatry), Catherine Stika, MD (Department of Obstetrics and Gynecology), Alfred George, MD (Department of Pharmacology)
Why is this research study important?
Preeclampsia is a serious medical condition affecting pregnancy. Certain chemicals in your blood may increase your risk of developing preeclampsia. A medicine called pravastatin, which you take by mouth, may decrease the levels of these chemicals. The purpose of this pilot study is to determine how the body handles Pravastatin during pregnancy and to determine its safety.
You may be eligible to participate if you:
- Are 18 years or older
- Currently between 12-16 weeks pregnant
- Have a documented history of prior severe PE, requiring delivery before 35 weeks gestation
- Blood draws
- Randomization to pravastatin or placebo
- 3 extended study day visits
- Follow up visits throughout the course of your pregnancy
- $25 for each completed blood draw visit
- $300 for each of the extended study day visits.
- Validation for on-site parking
For more information, please contact Minaz Kolia at 1-855-99-ASHER, or email email@example.com